Key Highlights

  • Shares are trading 33.00% higher at $0.2394 on Thursday, October 29, 2026.
  • A registered direct offering priced October 19 brought in about $3.75 million at $1.60 per share.
  • Warrants could expand the count from 1,046,390 Class A shares to as many as 30,458,162.
  • First-half 2026 revenue grew to about $12.94 million from about $10.27 million.
  • First-half net income was about $1.01 million, compared with a loss of about $1.98 million.

INLIF Surge: What Is Behind This Penny Stock's 33.00% Gain?

INLIF (NASDAQ:INLF) shares are trading 33.00% higher at $0.2394 on Thursday, October 29, 2026, from an implied prior close of about $0.18 (calculated). No dated company release accompanied the move, so recent filings supply the background.

INLIF is based in Quanzhou, China, and researches, develops, makes and sells manipulator arms for injection molding machines under the iNLIF brand. Its products include single, double and multi-axis arms, plus accessories, installation and warranty services. Founded in 2016, it has 156 employees.

The October 19 Deal: How Do the Warrants Affect the Share Count?

INLIF priced a registered direct offering with institutional investors on October 19 for gross proceeds of about $3.75 million, and the placement agent took a 7% fee. Units were priced at $1.60 per share, or $1.5999 per pre-funded warrant, covering 435,000 Class A shares and pre-funded warrants for up to 1,908,750 shares. Closing was expected on or about October 20.

Series A and Series B warrants each cover 2,343,750 shares at a $1.60 exercise price, with terms of five years and 60 days. Series C warrants can be exercised at $0.0001, with the number of shares fixed by a price-based adjustment over the first ten trading days. According to the prospectus, Series A and B prices may reset once on the 20th trading day to a lower level, subject to a $0.51 floor.

The prospectus showed 1,046,390 Class A shares before the deal, 3,390,140 afterward without warrant exercises, and 30,458,162 if all warrants were exercised.

Share Price Versus Deal Terms: How Wide Is the Gap?

The prospectus cited a last reported sale price of $2.55 on October 16. The implied prior close of about $0.18 (calculated) is far below the $1.60 offering price and the $0.51 reset floor, and today's $0.2394 is lower than all of them.

A 1-for-200 share combination took effect on July 6, 2026, intended to support the capital structure and Nasdaq compliance. Shares gained 37.73% to $5.95 in trading that day, according to market reports, an example of how sharply this thinly held stock can react to corporate actions.

First-Half Results: Are Higher Sales Restoring Profit?

Revenue for the six months ended June 30, 2026 was about $12.94 million against about $10.27 million, an increase of about 26% (calculated). Net income was about $1.01 million, versus a net loss of about $1.98 million a year before.

For full-year 2025, revenue was about $18.41 million with a net loss of about $5.45 million, following 2024 revenue of about $15.80 million and net income of about $1.63 million. In 2023, revenue was about $12.61 million and net income about $1.35 million.

What to Watch Next: Will Warrant Resets and the Series C Adjustment Add Shares?

Key dates include the ten-trading-day Series C adjustment window following the October 20 closing, the 20th trading day reset for Series A and B warrants, and the 60-day Series B expiry in December. Investors will also follow any further Nasdaq notices, other company filings and full-year 2026 results.